Niacin

Arxada and DSM target niacin growth as part of an extended long-term partnership

02-Sep-2022 By Nicola Gordon-Seymour

Chemicals specialist, Arxada, will increase production of niacin along with other ingredients, following an extension of a long-term collaboration with nutritional supplier, Royal DSM.

Jaksch says move into chairman role part of ChromaDex's pivot toward finished goods

14-May-2018 By Hank Schultz

A strategic pivot toward finished products underpins his impending move toward an advisory role, said ChromaDex CEO Frank Jaksch.

Is there a role for vitamin B3 in preventing birth defects?

15-Aug-2017 By Tim Cutcliffe

Adequate maternal niacin intake may cut the number of babies born with congenital abnormalities, suggests a new study in The New England Journal of Medicine.

Science Short

Niacin may have a role in melanoma prevention, suggests review

09-Aug-2017 By Tim Cutcliffe

Nicotinamide, a form of niacin, may have the potential to prevent melanoma in high-risk individuals, propose authors of a review.

Over double safe niacin content in recalled MusclePharm supplement

25-Apr-2016 By Annie Harrison-Dunn

The Food Safety Authority of Ireland (FSAI) has warned against MusclePharm’s pre-workout Assault Hybrid supplements after it was found they contained over double the safe upper limit for niacin.

Niagen nicotinamide riboside may reduce obesity-related inflammation

20-Nov-2015 By Stephen Daniells

Nicotinamide riboside, a vitamin B3 derivative, may reduce inflammation linked to obesity, and reduce the risk of diseases linked to this type of inflammation, according to pre-clinical data from scientists at the National Institutes of Health.

ChromaDex, P&G announce deal for nicotinamide riboside

05-Nov-2015 By Stephen Daniells

ChromaDex Corp. has entered into a joint development agreement with Procter & Gamble for development of forms of nicotinamide riboside (NR) for select applications.

News in brief

Chromadex reports 97% increase in ingredient sales

09-May-2014 By Stephen DANIELLS

The success and demand for Chromadex’s Niagen-branded nicotinamide riboside ingredient are driving ingredient sales for the Californian company, with more research to be published expected to further boost the ingredient.

Is B3 from Outer Space?

21-Apr-2014

NASA-funded researchers have identified traces of vitamin B3 have been in carbon-rich meteorites, supporting a theory that the origin of life may have been assisted by a supply of key molecules created in space and brought to Earth by comet and meteor...

Antioxidant combination may curb inflammation and manage dyslipidemia: Human data

02-Jul-2013 By Stephen DANIELLS

Supplements of vitamin E tocotrienol in combination with antioxidant polyphenols and niacin may improve inflammatory markers and reduce the risk of cardiovascular disease in seniors, says a recent clinical trial.

GMP compliance is a 'huge opportunity' for dietary supplements market: Chromadex CEO

07-Mar-2013 By Stephen Daniells in Irvine, CA

FDA enforcement of the current good manufacturing practices (cGMP) regulations is ‘a huge opportunity for the dietary supplements market’, says Frank Jaksch, CEO of Chromadex.

Slow-release niacin backed for lowering cholesterol, finds Lonza study

06-Feb-2013 By Nathan Gray

Slow-release niacin supplements are an effective way to lower cholesterol levels, while intake of inositol hexanicotinate (IHN) is ineffective, according to new research data.

Lonza to boost vitamin B3 capacity

04-Apr-2008 By Lorraine Heller

Lonza is to expand its production of vitamin B3 in a bid to meet
growing demand for the ingredient from the food industry, the
company has said.

Vertellus raises price of vitamin B3 for humans

05-Nov-2007 By Jess Halliday

Vertellus has announced a price hike for its vitamin B3 for human
nutrition - just as it is ramping up capacity of the vitamin at its
plants in Indianapolis and Antwerp.

Price rise for vitamin-B3

06-Jul-2007 By Alex McNally

Swiss biotech company Lonza has announced a worldwide price hike of
up to 12 per cent for vitamin B3 in a bid to pass-on increasing
production costs.

Lonza's poor nutrition margins persist in FY2005

25-Jan-2006 By staff reporter

Swiss chemicals group Lonza has reported a 38.8 percent increase in
operating income in 2005, but margins for its nutritional products
have been eroded by high costs.

Niacin prices going up

14-Oct-2005 By Dominique Patton

Swiss chemicals group Lonza is increasing the prices of its niacin
and niacinamide by between 10-12 per cent to absorb higher costs
for raw materials, energy and transportation, it said yesterday.

Higher demand for Lonza nutrition products but margins still weak

28-Jul-2005

Swiss fine chemicals group Lonza said yesterday that it saw strong
demand for its nutrition products during the first half but high
raw material and energy costs continued to erode margins, writes
Dominique Patton.

Niacin appears to protect against Alzheimer's too

16-Jul-2004

Dietary niacin, or vitamin B3, may protect against the development
of Alzheimer's disease and the cognitive decline associated with
ageing in older people, suggests new research.

Lack of iron, niacin may also raise risk of birth defects

08-Jun-2004

Expecting mothers with a diet lacking in plant proteins, iron,
magnesium, and niacin may be up to five times more likely to have a
baby with spina bifida, suggests a new study from the Netherlands.

Lonza offers slow release niacin for cholesterol-lowering products

19-May-2004

Swiss chemicals group Lonza has launched a slow release niacin that
almost eliminates the skin flushing commonly seen with the standard
vitamin.

Fish oil may 'partially' reduce cholesterol in diabetes patients

10-Oct-2002

Fish oil supplements could help reduce some of the fatty substances
found in the blood of diabetic patients, according to researchers
reporting in the October issue of Diabetes Care.

Niacin could be diabetes treatment

22-Jul-2002

Niacin, the B vitamin which is known to raise blood glucose levels
when consumed in large quantities - making it inappropriate for use
as a diabetes treatment - could in fact be effective in treating
the disease, provided the dosage...

Supplement users at risk from ignorance of tolerable upper limits

19-Jun-2002

Researchers from Canada have discovered that many dietary
supplement users are unaware of the tolerable upper limits and as
such could be putting themselves at risk instead of doing
themselves some good.